WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

NHSA Issues Notice to Enhance Drug Pricing and Procurement Credit Evaluation S... China's NHSA released a notification titled "Notice on Further Improving the Drug Pricing and Procurement Credit Evaluation System." This directive aims to strengthen ove...
(6/5/2025)

Following FDA's Elsa, China Accelerates AI Hea... (6/9/2025)

China Ascends to Global Leadership in Oncology... (6/5/2025)

Mainland Chinese Market for Weight Loss and Di... (6/5/2025)

Driving Business Growth Through Investment Fun... (6/4/2025)

2025 Outlook for Medtech in China (Simon Kuche... (6/2/2025)

China's Clinical Trial Boom (Asimov Press) (5/22/2025)

'China's Ozempic' may vie with Eli Lilly, Novo... (5/20/2025)

How Trump's Proposed Price Cuts Could Hurt Chi... (5/20/2025)

US Tariffs on Pharmaceuticals Could Hit Chines... (5/16/2025)

SMEI: China's Pharmaceutical Industry Seeks St... (5/16/2025)

Trump's Drug Pricing and the US-China Trade De... (5/12/2025)

China Still Go-To Source for New Drugs Despite... (5/9/2025)

Kelun-Biotech Secures US$250M in Upsized... (6/9/2025) Everest Presents Positive Results from P... (6/9/2025) Sihuan's Chinese NDA for Breast Cancer D... (6/9/2025) China Exempts U.S. Drugs & Medical Suppl... (6/9/2025) CDE Solicits Comments on Draft Guidance ... (6/9/2025) YolTech's YOLT‑101 Wins FDA IND Clearan... (6/9/2025) Livzon's siRNA Candidate YJH‑012 Approv... (6/9/2025) Argo's siRNA Candidate BW‑00163 Enters ... (6/9/2025) Recent Executive Moves (6/7/2025) QureBio Secures ~CNY 100M in Series C1 F... (6/7/2025) Zelgen and Merck Partner to Launch China... (6/6/2025) Beigene's BGB‑16673 Enters Phase 1b Tri... (6/6/2025) Qilu Launches Phase III Trial of QL1706 ... (6/6/2025) BMS's Reblozyl Approved in China for Low... (6/6/2025) AstraZeneca's Imfinzi Approved in China ... (6/6/2025) Keymed Launches First-in-Human Trial of ... (6/6/2025) AbbVie's Rinvoq (Upadacitinib) Gains App... (6/6/2025) Kelun‑Biotech Initiates Phase II Trial ... (6/6/2025)

China's Hospital Drug Market Shows Slight Growth in 202... China Unveils Ambitious Plan to Boost Health-Related Co... Chinese VMS OTC Market Growth Slowed to 2.7% in 2024 Newish Tech Secures Series B Financing to Advance Next-... China's Retail Pharmacy Market Reaches CNY 574 Billion ...

YolTech's YOLT‑101 Wins FDA IND Clearance as China Lic... China Exempts U.S. Drugs & Medical Supplies from Retali... Everest Presents Positive Results from Phase 1b/2a Tria... Kelun-Biotech Secures US$250M in Upsized HK Share Place... QureBio Secures ~CNY 100M in Series C1 Financing to Adv...

CDE Solicits Comments on Draft Guidance on Post-Approva... NMPA Reopens Comment on Draft Announcement for Strength... NMPA Issues New Regulations on Experimental Research of... CDE Issues Guideline on Safety Assessment and Reporting... CDE Launches “Starlight Plan” to Encourage Pediatric ...

NHSA Issues Notice to Enhance Drug Pricing and Procurem... China's Child Health Improves: NHC Official China Expands Geriatric Services at Major Hospitals as ... China's BMI Fund Reports Big Surplus in Q1/2025 China's Public Hospitals Grapple with Mounting Debt Ami...

AstraZeneca Faces Escalating Legal Challenges in China ... BeiGene Secures Key Patent Victory in Brukinsa Dispute ... State Council Approves Draft Medical Security Law, Stre... Novo Nordisk Sues KBP Biosciences for $830 Million Over... State Council Releases Final Antitrust Guidelines for t...

FDA Issues Warning Letters to Two Chinese API Manufactu... Implications of China's Growing Influence in Global Pha... FDA Issues Warning to Tianjin Darentang for Manufacturi... Shanghai Pharma Considers API Partnerships with Indian ... Aurobindo Challenges China in the Global Penicillin G M...

Argo's siRNA Candidate BW‑00163 Enters Phase 2 for Hyp... Livzon's siRNA Candidate YJH‑012 Approved for Clinical... Sihuan's Chinese NDA for Breast Cancer Drug Bireociclib... Akeso's Cadonilimab Gains First-Line Approval in Cervic... Kelun‑Biotech Initiates Phase II Trial of PTK7‑Target...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Former CFDA Commissioner Bi Jingquan Under Investigati... Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...